Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

40.14
-0.0900-0.22%
Volume:853.51K
Turnover:34.25M
Market Cap:96.18B
PE:21.53
High:40.31
Open:40.17
Low:39.92
Close:40.23
52wk High:52.68
52wk Low:39.18
Shares:2.40B
Float Shares:2.16B
Volume Ratio:0.56
T/O Rate:0.04%
Dividend:2.37
Dividend Rate:5.89%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.24
PE(LYR):10.68

Loading ...

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Amid Renewed US-Iran Clashes

MT Newswires Live
·
Jun 10

Dianthus sinks after Sanofi halts CIDP Phase 3 study

TIPRANKS
·
Jun 10

Sanofi to halt riliprubart Mobilize phase 3 study

TIPRANKS
·
Jun 10

Sanofi's Development Pipeline Stumbles Again as Rare Disease Drug Trial Halts, Adding Pressure on New CEO

Stock News
·
Jun 10

Sanofi Stops Late-Stage Trial of Autoimmune Disease Therapy After Interim Review

MT Newswires Live
·
Jun 10

Sanofi to Stop Late-Stage Study of Immune-Disorder Drug

Dow Jones
·
Jun 10

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live
·
Jun 08

Sanofi's Subcutaneous Sarclisa Approved in EU Across Multiple Myeloma Indications

MT Newswires Live
·
Jun 08

Movement Alert|Sanofi Rises 4.59% in Regular Trading, First-in-Class Drug Venglustat Granted FDA Priority Review for Rare Disease

Market Focus
·
Jun 04

Movement Alert|Sanofi Rises 3.09% in Pre-Market Trading, First-in-Class Drug Venglustat Granted FDA Priority Review

Market Focus
·
Jun 04

Sanofi's Groundbreaking Drug Venglustat Seeks FDA Approval for Type 3 Gaucher Disease

Stock News
·
May 28

Sanofi announces FDA grants priority review to venglustat new drug application

TIPRANKS
·
May 28

Sanofi Granted FDA Priority Review for Potential Treatment of Rare Gaucher Disease

MT Newswires Live
·
May 28

Sanofi reports ElevAATe trial of efdoralprin alfa meets primary endpoint

TIPRANKS
·
May 19

Regeneron Pharmaceuticals Trial Miss May Raise Broader Strategy Questions, RBC Says

MT Newswires Live
·
May 18

Sanofi’s SAR445399 Lung Trial Moves Ahead: What Investors Should Watch

TIPRANKS
·
May 15

Google AI legend raises big money for startup targeting this cutting-edge goal

Dow Jones
·
May 13

Global Pharmaceutical Giants Report Robust Earnings, Increasing Investments in China

Deep News
·
May 07

Sanofi Needs Acquisitions to Overcome Pipeline Disappointments -- Market Talk

Dow Jones
·
May 07

Regeneron, Sanofi present results from Dupixent Phase 4 trial

TIPRANKS
·
May 05